Slide NEWS & EVENTS

PRESS RELEASES

NEWS, EVENTS, PRESENTATIONS

CEO and Chairman of Alphyn Biologics talks with CONNECTpreneur Anchor and Phoenix Fund General Partner

Neal Koller, CEO and Chairman of Alphyn Biologics, talks with Laura Hill, CONNECTpreneur Anchor and Phoenix Fund General Partner in Tysons Corner, Virginia in February, 2020 Alphyn is a life science company developing proprietary drug therapy for treating serious skin diseases. The initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based…

Read more

BIO International 2019

BIO International 2019 Alphyn was selected to present at BIO International 2019 on June 6, 2019, in Philadelphia, Pennsylvania.  Chairman & CEO Neal Koller presented.

Read more